Pharmaceutical News and Articles

Rocket Pharmaceuticals Provides Update on Phase 2 Clinical Trial of RP-A501 for Danon Disease

Rocket Pharmaceuticals, Inc. (NASDAQ RCKT), a fully integrated, late-stage biotechnology company advancing an integrated pipeline of genetic therapies for rare

Ocugen Announces Rare Pediatric Disease Designation Granted for OCU410ST - Modifier Gene Therapy for the Treatment of Stargardt Disease

Ocugen, Inc. (Ocugen or the Company) (NASDAQ OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the United

Experimental Drug Development Centre Granted U.S. FDA Fast Track Designation for Antibody-Drug Conjugate EBC-129 to Treat Pancreatic Ductal Adenocarcinoma

Singapore, 28 May 2025 The Experimental Drug Development Centre (EDDC), Singapore s national platform for drug discovery and development, today announced that t

NIH Scientists Pioneer Promising Treatment for Intractable Cancer Pain

National Institute of Health (NIH) scientists report that a first-in-human clinical trial of a new therapy based on the plant-derived molecule resiniferatoxin (

Otsuka Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)

Patritumab Deruxtecan Biologics License Application for Patients with Previously Treated Locally Advanced or Metastatic EGFRMutated Non-Small Cell Lung Cancer Voluntarily Withdrawn

Stealth BioTherapeutics Announces “Path Forward” Despite Disappointing Delay for Ultra-Rare Barth Syndrome

HPV Genome Sequencing Superior in Detecting Head & Neck Cancer

Human papillomavirus (HPV) whole-genome sequencing (WGS)-based circulating tumor DNA (ctDNA) detection has the highest sensitivity, specificity, and diagnostic

MRI, Mammography Outperform Whole Breast Ultrasound for Dense Breasts

Abbreviated magnetic resonance imaging (MRI) and contrast-enhanced mammography detect more cancers and invasive cancers than automated whole breast ultrasound (

Youth Deaths Attributable to Synthetic Opioids Alone Increasingly Predominant

Among U.S. youth, overdose deaths attributable to synthetic opioids alone are increasingly predominant, according to a study published online May 20 in Pediatri